Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-20 · accession 0001415889-25-018014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-23 | 2025-06-20+ | ORIC | You Angie | Dir | P - Purchase | $9.39 | +28.0K | 26.6K | New | +$263.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-23 | P | A | 1,403 | $9.43 | 28,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-20 | P | A | 26,597 | $9.39 | 26,597 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 26,597 shares purchased in the price range of $9.14 to $9.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |